Nuclear translocation of urokinase-type plasminogen activator

Blood

Volumn 112, Issue 1, 2008, Pages 100-110

  Stepanova, Victoria ^a,b,e   Lebedeva, Tatiana ^a   Kuo, Alice ^a   Yarovoi, Serge ^a   Tkachuk, Sergei ^c   Zaitsev, Sergei ^a   Bdeir, Khalil ^a   Dumler, Inna ^c   Marks, Michael S ^a   Parfyonova, Yelena ^b   Tkachuk, Vsevolod A ^b   Higazi, Abd Al Roof ^a,d   Cines, Douglas B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d HEBREW UNIVERSITY   (Israel)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; LOW DENSITY LIPOPROTEIN RECEPTOR; NUCLEOLIN; PROUROKINASE; UROKINASE; UROKINASE RECEPTOR; ACTIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MESSENGER RNA; PHOSPHOPROTEIN; RECOMBINANT PROTEIN; RNA BINDING PROTEIN; SMALL INTERFERING RNA;

ARTICLE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RNA INTERFERENCE; ACTIVE TRANSPORT; ANIMAL; CELL CULTURE; CHEMISTRY; DRUG ANTAGONISM; GENE DELETION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HELA CELL; KINETICS; METABOLISM; MOUSE; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; SIGNAL TRANSDUCTION;

ACTINS; ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; BASE SEQUENCE; CELLS, CULTURED; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; KINETICS; LDL-RECEPTOR RELATED PROTEINS; MICE; PHOSPHOPROTEINS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; SEQUENCE DELETION; SIGNAL TRANSDUCTION; TRANSFECTION; URINARY PLASMINOGEN ACTIVATOR;

EID: 47249109051     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-07-104455     Document Type: Article

References (71)

1. Alfano D, Franco P, Vocca I, et al. The urokinase plasminogen activator and its receptor: role in cell growth and apoptosis. Thromb Haemost. 2005; 93:205-211.
2. Appella E, Robinson EA, Ullrich SJ, et al. The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases. J Biol Chem. 1987;262:4437-4440.
3. Lijnen HR, Van Hoef B, Nelles L Holmes WE, Collen D. Enzymatic properties of single-chain and two-chain forms of a Lys158→Glu158 mutant of urokinase-type plasminogen activator. Eur J Biochem. 1988;172:185-188.
4. Herz J, Glouthier DE, Hammer RE. LDL receptorrelated protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation. Cell. 1992;71:411-421.
5. Nykjaer A, Conese M, Christensen El, etal. Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes. EMBO J. 1997;16:2610-2620.
6. Kjoller L. The urokinase plasminogen activator receptor in the regulation of the actin cytoskeleton and cell motility. Biol Chem. 2002;383:5-19.
7. Blasi F, Carmeliet P. uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol. 2002;3:932-943.
8. Poliakov A, Tkachuk V, Ovchinnikova T, Potapenko N, Bagryantsev S, Stepanova V. Plasmin-dependent elimination of the growth-factorlike domain in urokinase causes its rapid cellular uptake and degradation. Biochem J. 2001;355:639-645.
9. Mukhina S, Stepanova V, Traktouev D, et al. The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain: characterization of interactions and contribution to chemotaxis. J Biol Chem. 2000;275:16450-16458.
10. Haj-Yehia A, Nassar T, Sachais BS, et al. Urokinase-derived peptides regulate vascular smooth muscle contraction in vitro and in vivo. FASEB J. 2000;14:1411-1422.
11. Pluskota E, Soloviev DA, Plow EF. Convergence of the adhesive and fibrinolytic systems: recognition of urokinase by integrin alpha M beta 2 as well as by the urokinase receptor regulates cell adhesion and migration. Blood. 2003;101:1582-1590.
12. Shetty S, Bdeir K, Cines DB, Idell S. Induction of plasminogen activator inhibitor-1 by urokinase in lung epithelial cells. J Biol Chem. 2003;278:18124-18131.
13. Shetty S, Pendurthi UR, Halady PK, Azghani AO, Idell S. Urokinase induces its own expression in Beas2B lung epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2002;283:L319-L328.
14. Shetty S, Gyetko MR, Mazar AP. Induction of p53 by urokinase in lung epithelial cells. J Biol Ghem. 2005;280:28133-28141.
15. Rabbani SA, Gladu J, Mazar AP, Henkin J. Goltzman D. Induction in human osteoblastic cells (SaOS2) of the early response genes fos, jun. and myc by the amino terminal fragment (ATF) of urokinase. J Cell Physiol. 1997;172:137-145.
16. NassarT, Haj-Yehia A, Akkawi S, et al. Binding of urokinase to low density lipoprotein-related receptor (LRP) regulates vascular smooth muscle cell contraction. J Biol Chem. 2002;277:40499-40504.
17. Dumler I, Stepanova V, Jerke U, et al. Urokinaseinduced mitogenesis is mediated by casein kinase 2 and nucleolin. Curr Biol. 1999;9:1468-1476.
18. Tuteja R, Tuteja N. Nucleolin: a multifunctional major nucleolar phosphoprotein. Grit Rev Biochem Mol Biol. 1998;33:407-436.
19. Srivastava M, Pollard HB. Molecular dissection of nucleolin's role in growth and cell proliferation: new insights. FASEB J. 1999;13:1911-1922.
20. Christian S, Pilch J, Akerman ME, PorkkaK, Laakkonen P, Ruoslahti E. Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels. J Cell Biol. 2003; 163:871-878.
21. Huang Y, Shi H, Zhou H, Song X, Yuan S, Luo Y. The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin. Blood. 2006:107:3564-3571.
22. Shi H, Huang Y, Zhou H, et al. Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin. Blood. 2007;110:2899-2906.
23. Wang Y, Guan J, Wang H, Leeper D, lliakis G. Regulation of dna replication after heat shock by replication protein a-nucleolin interactions. J Biol Chem. 2001;276:20579-20588.
24. Kim K, Dimitrova DD, Carta KM, Saxena A, Daras M, Borowiec JA. Novel checkpoint response to genotoxic stress mediated by nucleolin-replication protein a complex formation. Mol Cell Biol. 2005;25:2463-2474.
25. Borer RA, Lehner CF, Eppenberger HM, Nigg EA. Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell. 1989;56:379-390.
26. Bouvet P, Diaz JJ, KindbeiterK, MadjarJJ, Amalric F Nucleolin interacts with several ribosomal proteins through its RGG domain. J Biol Chem. 1998;273:19025-19029.
27. Schmidt-Zachmann MS, Dargemont C, Kuhn LC, Nigg EA. Nuclear export of proteins: the role of nuclear retention. Cell. 1993;74:493-504.
28. Shibata Y, Muramatsu T, Hirai M, et al. Nuclear targeting by the growth factor midkine. Mol Cell Biol. 2002;22:6788-6796.
29. Said EA, Courty J, Svab J, Delbe J, Krust B, Hovanessian AG. Pleiotrophin inhibits HIV infection by binding the cell surface-expressed nucleolin. Febs J. 2005;272:4646-4659.
30. Semenkovich CF, Ostlund RE Jr, Olson MO, Yang JW. A protein partially expressed on the surface of HepG2 cells that binds lipoproteins specifically is nucleolin. Biochemistry. 1990;29:9708-9713.
31. Kibbey MC, Johnson B, Petryshyn R, Jucker M, Kleinman HK. A 110-kD nuclear shuttling protein, nucleolin, binds to the neurite-promoting IKVAV site of laminin-1. J Neurosci Res. 1995;42:314-322.
32. Harms G, Kraft R, Grelle G, Volz B, Dernedde J, Tauber R. Identification of nucleolin as a new Lselectin ligand. Biochem J. 2001;360:531-538.
33. Legrand D, Vigie K, Said EA, et al. Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells. Eur J Biochem. 2004;271:303-317.
34. Qiu J, Brown KE. A110-kDa nuclear shuttle protein, nucleolin, specifically binds to adeno-associated virus type 2 (AAV-2) capsid. Virology. 1999; 257:373-382.
35. Nisole S, Krust B, Hovanessian AG. Anchorage of HIV on permissive cells leads to coaggregation of viral particles with surface nucleolin at membrane raft microdomains. Exp Cell Res. 2002;276:155-173.
36. Bdeir K, Kuo A, Sachais BS, et al. The kringle stabilizes urokinase binding to the urokinase receptor. Blood. 2003;102:3600-3608.
37. Willnow TE, Herz J. Genetic deficiency in low density lipoprotein receptor-related protein confers cellular resistance to Pseudomonas exotoxin A. Evidence that this protein is required for uptake and degradation of multiple ligands. J Gell Sci. 1994;107(pt3):719-726.
38. Lin SY, Makino K, Xia W, et al. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol. 2001;3:802-808.
39. Blobel G, Potter VR. Nuclei from rat liver: isolation method that combines purity with high yield. Science. 1966;154:1662-1665.
40. Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol. 1997;15:871-875.
41. Yuan B, Latek R, Hossbach M, Tuschl T, Lewitter F. siRNA Selection Server: an automated siRNA oligonucleotide prediction server. Nucleic Acids Res. 2004;32:W130-W134.
42. Ausubel FM, Brent R, Kingston RE, et al. Current Protocols in Molecular Biology. Suppl 60. New York, NY: John Wiley & Sons; 2002.
43. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402-408.
44. Roldan AL, Cubellis MV, Masucci MT, et al. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO J. 1990;9:467-474.
45. Blasi F, Stoppelli MP, Cubellis MV. The receptor for urokinase- plasminogen activator. J Cell Biochem. 1986;32:179-186.
46. Abmayr S, Yao T, Parmely T, Workman JL. Preparation of nuclear and cytoplasmic extracts from mammalian cells. In: Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K, eds. Current Protocols in Molecular Biology. Vol 2. New York, NY: John Wiley & Sons; 2006;(suppl 75):12.71.71-12.71.10.
47. Ginisty H, Sicard H, Roger B, Bouvet P. Structure and functions of nucleolin. J Gell Sci. 1999;112:761-772.
48. Nykjaer A, Kjoller L, Cohen RL, et al. Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein: evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor. J Biol Chem. 1994;269:25668-25676.
49. Kounnas MZ, Henkin J, Argraves WS, Strickland DK. Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor mediates cellular uptake of pro-urokinase. J Biol Ghem. 1993; 268:21862-21867.
50. Creancier L, Prats H, Zanibellato C, Amalric F, Bugler B. Determination of the functional domains involved in nucleolar targeting of nucleolin. Mol Biol Cell. 1993;4:1239-1250.
51. Schwab MS, Dreyer C. Protein phosphorylation sites regulate the function of the bipartite NLS of nucleolin. Eur J Cell Biol. 1997;73:287-297.
52. Plekhanova OS, Stepanova VV, Ratner El, Bobik A, Tkachuk VA, Parfyonova YV. Urokinase plasminogen activator in injured adventitia increases the number of myofibroblasts and augments early proliferation. J Vase Res. 2006;43:437-446.
53. Goncharova EA, VorotnikovAV, Gracheva EO, et al. Activation of p38 MAP-kinase and caldesmon phosphorylation are essential for urokinase-induced human smooth muscle cell migration. Biol Chem. 2002;383:115-126.
54. Tarui T, Akakura N, Majumdar M, et al. Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin alpha v beta 3 induces signal transduction and enhances plasminogen activation. Thromb Haemost. 2006; 95:524-534.
55. Kim KS, Hong YK, Joe YA, et al. Anti-angiogenic activity of the recombinant kringle domain of urokinase and its specific entry into endothelial cells. J Biol Chem. 2003;278:11449-11456.
56. Semenkovich CF, Ostlund RE Jr, Olson MO, et al. A protein partially expressed on the surface of HepG2 cells that binds lipoproteins specifically is nucleolin. Biochemistry. 1990;29:9708-9713.
57. Said EA, Krust B, Nisole S, Svab J, Briand JP, Hovanessian AG. The anti-HIV cytokine rnidkine binds the cell surface-expressed nucleolin as a low affinity receptor. J Biol Chem. 2002;277:37492-37502.
58. Kubler D. Ecto-protein kinase substrate p120 revealed as the cell-surface-expressed nucleolar phosphoprotein Nopp140: a candidate protein for extracellular Ca2 + -sensing. Biochem J. 2001; 360;579-587.
59. Saldanha RG, Molloy MP, Bdeir K, et al. Proteomic identification of lynchpin urokinase plasminogen activator receptor protein interactions associated with epithelial cancer malignancy. J Proteome Res. 2007;6:1016-1028.
60. Schmitt MF, Janicke F, Moniwa N, Chuchlowski N, Pache L, Graeff H. Tumor-associated urokinase-type plasminogen activator: biological and clinical significance. Biol Chem Hoppe Seyler. 1992;376:611-622.
61. de Vries TJ, Quax PHA, Denijn M, et al. Plasminogen activators, their inhibitors, and urokinase receptors emerge in later stages of melanocytic tumor progression. Am J Pathol. 1994; 144:70-81.
62. Min HY, Doyle LV, Vitt CR, et al. Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice. Cancer Res. 1996;56:2428-2433.
63. Castellino FJ, Ploplis VA. Structure and function of the plasminogen/plasmin system. Thromb Haemost. 2005;93:647-654.
64. Wesche J, Malecki J, Wiedlocha A, Skjerpen CS, Glaus P, Olsnes S. FGF-1 and FGF-2 require the cytosolicchaperone Hsp90 for translocation into the cytosol and the cell nucleus. J Biol Chem. 2006;281:11405-11412.
65. Malecki J, Wesche J, Skjerpen GS, Wiedlocha A, Olsnes S. Translocation of FGF-1 and FGF-2 across vesicular membranes occurs during G1-phase by a common mechanism. Mol Biol Cell. 2004;15:801-814.
66. Hinz B, Celetta G, Tomasek JJ, Gabbiani G, Chaponnier C. Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell. 2001;12:2730-2741.
67. Ronnov-Jessen L, Petersen OW. Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts: implications for myofibroblast generation in breast neoplasia. Lab Invest. 1993;68:696-707.
68. Skrypina NA, Savochkina LP, Beabealashvilli R. In vitro selection of single-stranded DNA aptamersthat bind human pro-urokinase. Nucleosides Nucleotides Nucleic Acids. 2004; 23:891-893.
69. Tuteja N, Huang NW, Skopac D, et al. Human DNA helicase IV is nucleolin, an RNA helicase modulated by phosphorylation. Gene. 1995;160:143-148.
70. Dickinson LA, Kohwi-Shigematsu T Nucleolin is a matrix attachment region DNA-binding protein that specifically recognizes a region with high base-unpairing potential. Mol Gell Biol. 1995;15:456-465.
71. Grinstein E, Wernet P, Snijders PJ, et al. Nucleolin as activator of human papillomavirus type 18 oncogene transcription in cervical cancer. J Exp Med. 2002;196:1067-1078.